Stephanie Sacharow, MD

Clinical Genetics and Inborn Errors of Metabolism, special interest in dysmorphology, developmental disabilities, and Phenylketonuria (PKU)

Dr. Stephanie Sacharow is a medical geneticist experienced in the management of patients with a variety of genetic conditions and metabolic disease. She was involved with the implementation and execution of expanded newborn screening for metabolic disease in South Florida and participated on the craniofacial team. She enjoys working with patients and families to help them through their diagnostic journeys. She has been involved in research studies with a focus on autism, genomic imbalances, inborn errors of metabolism and other rare disorders. Dr. Sacharow is board certified in Pediatrics, Medical Genetics and Medical Biochemical Genetics, and has been practicing over 15 years.
Dr. Sacharow was recruited to Boston Children’s Hospital/Harvard Medical School in 2015. Dr. Sacharow is the medical director of the PAL clinic at Boston Children’s Hospital and the director of the Dr Harvey Levy Program for Phenylketonuria and Related Conditions. Dr. Sacharow has published numerous articles and is co-investigator in multiple clinical trials for Phenylketonuria and Homocystinuria. Dr. Sacharow is also a provider for the the BoLD Lysosomal Storage Disease Program.

Dr Sacharow sees patients in clinic at Boston Children’s Hospital.

< BACK TO DIRECTORY